Sodium Phenylacetate And Sodium Benzoate Injection, Solution, Concentrate
Product Images NDC 68475-001

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 68475-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2ff6227b 08a2 471e 8b3c B1ec47b43248 01

Chemical structure diagrams of Sodium Phenylacetate and Sodium Benzoate, showing the molecular arrangements for each compound in the Sodium Phenylacetate and sodium benzoate injection solution concentrate.*

FDA Label Image

2ff6227b 08a2 471e 8b3c B1ec47b43248 02

Illustration of a metabolic pathway showing the urea cycle and related biochemical conversions involving benzoate, glycine, glutamate, and phenylacetate. It depicts intermediates such as carbamyl phosphate, citrulline, argininosuccinate, arginine, and related enzymes including CPS, NAGS, OTC, ASS, ARG, and ASL. The diagram highlights urine excretion processes of hippurate and phenylacetylglutamine, as well as supplemented arginine and production of urea and fumarate.*

FDA Label Image

2ff6227b 08a2 471e 8b3c B1ec47b43248 03

Label for Sodium Phenylacetate and Sodium Benzoate Injection 10% / 10%, 50 mL concentrate solution for intravenous use. The label includes the product name, concentration, volume, manufacturer Navinta LLC, and storage instructions. It emphasizes use by intravenous administration and warning about central line use.*

FDA Label Image

2ff6227b 08a2 471e 8b3c B1ec47b43248 04

Label for Sodium Phenylacetate and Sodium Benzoate Injection 10% / 10%, 50 mL concentrate solution for intravenous use, manufactured by Navinta LLC. The label includes dosage instructions, a warning that the solution must be diluted before IV administration, storage conditions, and the NDC number 68475-001-50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.